Board Director | CEO, Atsena Therapeutics, INC

Pat Ritschel

Pat holds a B.S. in Mechanical Engineering from the University of Illinois and an MBA from Washington University in St. Louis, and has over 20 years of experience in business management, business development, technology licensing, equipment/product sales, and engineering. Pat has plant operations/maintenance experience with Air Products and Chemicals, later joining Monsanto Enviro-Chem Systems where he held a variety of design engineering, sales, and business management positions. In 2003, he relocated to Hong Kong to lead the Asia-Pacific business of Monsanto Enviro-Chem and in 2005, he joined other members of senior management to acquire the company in a management buyout. From 2005 – 2010, Pat led the Asia-Pacific business of the privately held company, establishing local entities and growing the business significantly. Following the sale of the company to DuPont in 2010, Pat relocated to Wilmington, Delaware as Director, Business Development for DuPont Clean Technologies. Pat has served as a Director of Monsanto Far East Ltd, MECS Far East Limited, MECS Shanghai, MECS-Tongren Joint Venture, Monsanto-DMCC Joint Venture, MECS India Private Limited, and MECS Enterprises Private Limited. Pat left DuPont in 2013 and is focused on supporting FARA to find a cure for FA.